Cargando…

Development and Validation of Prognostic Model in Transitional Bladder Cancer Based on Inflammatory Response-Associated Genes

BACKGROUND: Bladder cancer is a common malignant type in the world, and over 90% are transitional cell carcinoma. While the impact of inflammatory response on cancer progression has been reported, the role of inflammatory response-associated genes (IRAGs) in transitional bladder cancer still needs t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Zhiwen, Cai, Jinming, Sun, Wenlan, Hua, Shan, Wang, Xingjie, Li, Anguo, Jiang, Juntao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529162/ https://www.ncbi.nlm.nih.gov/pubmed/34692520 http://dx.doi.org/10.3389/fonc.2021.740985

Ejemplares similares

Identification and Validation of a Novel Immune-Related lncRNA Signature for Bladder Cancer
por: Hua, Shan, et al.
Publicado: (2021)

A nomogram for predicting the risk of residual stone fragments after ureteroscopy
por: Zhang, Yongqing, et al.
Publicado: (2023)

Identification and validation of an immune-related gene prognostic signature for clear cell renal carcinoma
por: Hua, Shan, et al.
Publicado: (2022)

Tumour microenvironment landscape and immunotherapy response in bladder cancer decoded by stromal MOXD1 based on copper-related genes signature
por: Wang, Wenhao, et al.
Publicado: (2022)

Construction and Validation of an Autophagy-Related Prognostic Signature and a Nomogram for Bladder Cancer
por: Yan, Xin, et al.
Publicado: (2021)

Identification and Validation of the Prognostic Stemness Biomarkers in Bladder Cancer Bone Metastasis
por: Kang, Yao, et al.
Publicado: (2021)

Prognostic Value of the Systemic Inflammatory Response Index in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Population-Based Study
por: Ni, Jinliang, et al.
Publicado: (2021)

Development and validation of prognostic index based on immunogenic cell death-related genes with melanoma
por: Han, Yajun, et al.
Publicado: (2022)

Development and Validation of a Prognostic Model for Predicting Overall Survival in Patients With Bladder Cancer: A SEER-Based Study
por: Wang, Wei, et al.
Publicado: (2021)

Inflammatory myofibroblastic tumor of the urinary bladder: A prognostically favorable spindle cell neoplasm
por: Laylo, John Carlo V., et al.
Publicado: (2020)

Development and validation of a prognostic nomogram for gallbladder papillary adenocarcinoma
por: Wang, Zhenfeng, et al.
Publicado: (2023)

Development and Validation of a Prognostic Nomogram for Predicting Cancer-Specific Survival in Patients With Lymph Node Positive Bladder Cancer: A Study Based on SEER Database
por: Zhan, Xiangpeng, et al.
Publicado: (2022)

Development and Validation of a Prognostic Signature for Malignant Pleural Mesothelioma
por: Zhou, Jian-Guo, et al.
Publicado: (2019)

The Epithelial to Mesenchymal Transition Related Gene Calumenin Is an Adverse Prognostic Factor of Bladder Cancer Correlated With Tumor Microenvironment Remodeling, Gene Mutation, and Ferroptosis
por: Du, YiHeng, et al.
Publicado: (2021)

External Validation of the Prognostic Value of an Immune-Associated Gene Panel for Clear Cell Renal Cell Carcinomas
por: Xie, Zhiwen, et al.
Publicado: (2021)

Application of intra-arterial chemotherapy in high-risk non-muscle invasive bladder cancer: a systematic review and meta-analysis
por: You, Chengyu, et al.
Publicado: (2021)

Corrigendum: The epithelial to mesenchymal transition related gene calumenin is an adverse prognostic factor of bladder cancer correlated with tumor microenvironment remodeling, gene mutation, and ferroptosis
por: Du, YiHeng, et al.
Publicado: (2023)

Transitional Bladder Cell Carcinoma Spreading to the Skin
por: Kerkeni, W., et al.
Publicado: (2017)

Development and Validation of a 6-miRNA Prognostic Signature in Spinal Chordoma
por: Huang, Wei, et al.
Publicado: (2020)

Development and validation of cuproptosis-associated prognostic signatures in WHO 2/3 glioma
por: Ye, Zhang, et al.
Publicado: (2022)

Development and Validation of a Prognostic Nomogram for Hypopharyngeal Carcinoma
por: Tian, Shu, et al.
Publicado: (2021)

Identify and validate RUNX2 and LAMA2 as novel prognostic signatures and correlate with immune infiltrates in bladder cancer
por: Jin, Yi, et al.
Publicado: (2023)

Identification of Feature Genes of a Novel Neural Network Model for Bladder Cancer
por: Zhang, Yongqing, et al.
Publicado: (2022)

Biliary Neuroendocrine Neoplasms: Analysis of Prognostic Factors and Development and Validation of a Nomogram
por: Zhou, Shengnan, et al.
Publicado: (2021)

Metastatic inflammatory myofibroblastic tumor of the bladder
por: Libby, Emma K., et al.
Publicado: (2018)

Development and Validation of a Prognostic Index Based on Genes Participating in Autophagy in Patients With Lung Adenocarcinoma
por: Wu, Zi-Xuan, et al.
Publicado: (2022)

Development and Validation of an RNA-Seq-Based Prognostic Signature in Neuroblastoma
por: Zhou, Jian-Guo, et al.
Publicado: (2019)

Development and Validation of an Immune-Related Prognostic Signature in Cervical Cancer
por: Su, Rongjia, et al.
Publicado: (2022)

Development and External Validation of a Novel 12-Gene Signature for Prediction of Overall Survival in Muscle-Invasive Bladder Cancer
por: Abudurexiti, MierXiati, et al.
Publicado: (2019)

Identification and Validation of N6-Methyladenosine-Related Biomarkers for Bladder Cancer: Implications for Immunotherapy
por: Deng, Hongyu, et al.
Publicado: (2022)

Development and validation of prognostic models for colon adenocarcinoma based on combined immune-and metabolism-related genes
por: Jiang, Hui-zhong, et al.
Publicado: (2022)

Effect of unfolded protein response on the immune infiltration and prognosis of transitional cell bladder cancer
por: Yan, Xiaokai, et al.
Publicado: (2021)

The relationship between inflammatory response markers and the prognosis of non-muscle invasive bladder cancer and the development of a nomogram model
por: Yi, Xinping, et al.
Publicado: (2023)

Integrative Analysis Identified MCT4 as an Independent Prognostic Factor for Bladder Cancer
por: Zhao, Yang, et al.
Publicado: (2021)

OSblca: A Web Server for Investigating Prognostic Biomarkers of Bladder Cancer Patients
por: Zhang, Guosen, et al.
Publicado: (2019)

Development and Validation of a Prognostic Nomogram to Predict Cancer-Specific Survival in Adult Patients With Pineoblastoma
por: Jing, Yajun, et al.
Publicado: (2020)

Development and Validation of a Prognostic Nomogram for Extremity Soft Tissue Leiomyosarcoma
por: Xue, MingFeng, et al.
Publicado: (2019)

Development and Validation of a Clinical Prognostic Nomogram for Esophageal Adenocarcinoma Patients
por: Shao, Chen-ye, et al.
Publicado: (2021)

Development and validation of a prognostic 9-gene signature for colorectal cancer
por: Cui, Junpeng, et al.
Publicado: (2022)

Development and validation of a prognostic nomogram for extrahepatic bile duct adenocarcinoma
por: Zhang, Shiyao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1scu94tqfq27dh88i5kjcd2ifh